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The present use of anticoagulants is hampered by the necessity of giving a number of injections of heparin each day, or of using an oral anticoagulant which acts by throttling prothrombin delivery from the liver and does not seem to be a safe anticoagulant, since its laboratory control is not standardized. Because of this an attempt is made in this paper to show the effectiveness of administering heparin subcutaneously and of giving only enough to restore the clotting mechanism to its normal level but not necessarily prolonging the clotting time. With this principle a single injection of heparin a day or every second day seems sufficient, and the danger of hemorrhage is greatly minized.
B ECAUSE there is a definite need for an anticoagulant which need not be injected intravenously, and because of our conviction that dicumarol prophylaxis and therapy are at present unsafe and unpredictable,' an investigation of various heparin solutions and suspensions w-as undertaken with regard to their injectability and efficacy through a deep subcutaneous route. When the site of so-called intramuscular injections as given by the nursing staff is examined by biopsy, it is often found to be the deep subcutaneous tissue. The samples tested were 200 mg. of heparin in gelatin,* with and without vasoconstrictors, 400 Figure 1 shows a control of this drug by venous coagulation times. Note that the effect is over in about 12 hours and that the peaks are so high as to make the venous coagulation times impractical. Figure 2 shows the control by capillary coagulation times. Thus, case 6 in figure 2 shows a poor response. This patient, Esther 0., a heavy set woman with chronic thrombophlebitic edema, showed marked heparin resistance following operation. In contrast, case 3, a young boy who had just recovered from a massive acute thromb)ophle-bitis, showed a good response. The same heparin sensitivity is exhibited by case 4, figure 1, a patient with Buerger's disease in a state of remission.
(2) 200 MAIg. of Depo-Heparin with Vasoconstrictors. Figure 3 shows the control with venous coagulation times, whereas figure 4 illustrates the control by capillary coagulation of 56, with extensive arterial and venous thrombosis who showed little therapeutic effect; even less did case 6, Charlotte K., who exhibited a postoperative infection. The average duration of effect, which varied from 9 hours to 30 hours, was 22 hours. times. The highest response in figure 3 is shown by case T'he N\eutralization of Hepasint by I'rotatninc SulfJate Various doses of protamine sulfate were given intravrenously to neutralize the action of heparin ( fig. 9 ). While a 1 :1 ratio of protamine to heparin definitely dampens the effect of hepatin, a complete suppression of the heparin effect on capillary coagulation time is obtained by a 1.5:1 ratio. Thus 75 mg. of protamine sulfate given simultaneously (but not in the same syringe) with 50 mg. of heparin, has led to the flattening of clotting curves.
When protamine sulfate is given at the height of the clotting curve, within 10 minutes there is a steep fall of the clotting time to a lower level.
Here again a 1.5:1 ratio (i.e. 75 mg. of protamine to 50 mg. of heparin) seems the most effective, but smaller (loses, such as a 0.5: 1 ratio, are partially effective. (fig. 9 ).
So far, there havre been no untoward reactions following the intravenous use of protamine; when given into muscle there is severe burning for 24 hours, but a noticeable antiheparin effect. We do not advise the latter method of aclministration unless it can be made more painless, possibly with procaine ais in the case of aminophylline.
The duration of the effect of intrav enous protamine is approximately four hours. Heparin response up to four hours is abolished or dampened. In case of continuing hemorrhage after administration of heparin, protamine injections must be repeate(l.
DI)iscvussIoNx
With increasing experience we have (leveloped certain guiding principles which of course may have to be modified in the light of further observations. In addition to the factors enumerated in table 1, weight is an important factor in determining heparin response. This is illustrated by patient Wm. P., who received preoperatively 400 mg. of Depo-heparin without vasoconstrictors, resulting in a capillary coagulation time of 32 minutes with a duration of effect to 38 hours, and a large hematoma at the site of injection. The amount he received was equivalent to 3.5 mg. per pound of body weight; in our opinion 2 mg. per pound is sufficient as a preoperative or therapeutic dose. 1Postopera-tivrely, even the 2 mg. per pound weight dose may be too much, as shown by the case of Vesta MW., who received 300 mg. of Depo-heparin (1.71 mg. per pound of body wveight) and developed a huge hematoma in the incision of a lumbar sympathectomy. This patient had no thrombosis at the time, but had had this condition in the past. In postoperative prophylaxis 1 mg. of heparin per poun(l of body weight is a safer daily dose.
This matter raises the question of the adv:isability of giving large doses of heparin intramuscularly the absorption of which is not under any further control than that given by the gelatin-dextrose menstruum and the vasoconstrictor. However, even with 200 mg. given in 10 per cent aqueous solution, we have observed a severe hemorrhage from an unstuspected cervical erosion in Viola AI., who required several transfusions to restore her blood count.
In addition, heparin seems to have a cumulative effect, because a patient whose coagulation time has returned to normal may respond the second and third time with a far longer coagulation time or even with hemorrhage. There are several possible explanations for this which we plan to investigate in the future. Suffice it to say here that, once the patient has received a large dose of heparin, the heparin requirement diminishes, and the return of the capillary coagulation time to a normal level does not mirror the increased sensitivity. Increased heparin sensitivity may be due to several factors, some of which are listed in table 1. From the standpoint of avoiding hemorrhages after heparin administration the following points need emphasis: (1) Small amounts of heparin remain in the blood stream, although only a single dose of heparin is given for a longer time than venous or capillary coagulation times can detect them. They are demonstrable, however, with a heparin clotting time or heparin titration.* (2) After certain shocklike states, including coronary thrombosis, pulmonary embolism and massive peripheral thrombosis, anticoagulant substances appear in the blood,10 and they may manifest themselves by increased reactivity to heparin (case 10 of figure 3 , and cases 3 and 9 of figure 2). We have again and again seen astonishing responses to heparin after the 10 mg. test dose in patients who were recovering from or had just suffered an acute thrombosis. In such patients This brings us to the important question: what is the desirable range of capillary coagulation time, a range which is both safe and protective against thrombosis or extension of thrombosis? Our experience, extending over 12 years, indicates that for therapeutic purposes a range between 8 and 12 minutes is effective. There is no need to reach peaks of 20 to 30 minutes. This is uneconomical because so much more of the drug will be excreted through the kidney. Therefore, the plateau type of curve is preferable. The heparin-gelatin emulsion is sometimes painful. While it is a definite improvement over the Pitkin menstruum, our records indicate a 15 per cent incidence of pain of which patients spontaneously complain, some of course more bitterly than others. A study of the graphs presented indicates that the variability of the patient's response to heparin is great. The value of mass statistics, transferred to punch cards and analyzed for statistical significance, is not questioned; but they will not substitute for a close clinical observation of each patient receiving anticoagulants. The balance of coagulant and anticoagulant factors is delicate and seems to swing spontaneously; the administration of an anticoagulant markedly influences this balance.
Regarding dosage schedules, the following tentative schedule has been followed: a priming dose of intravenous heparin (30 to 50 mg.) is followed by the deep subcutaneous injection of heparin in gelatin. The of an open lesion, or of a recent surgical incision, this dose must never be exceeded, but may even be split by giving it every second day.
Control of the clotting mechanism is sufficiently safe if a capillary coagulation time is determined once a day, usually in the morning, with the heparin administered at noon-time. When a sensitized clotting time is used, this too can be run once a day and should be kept at the upper limit of normal. Such a control leads to smaller prophylactic doses than have been employed in the past. 9 Aside from occasional sensitization to heparin, the only complication of heparin administration is hemorrhage. The following precautions are useful in minimizing this untoward reaction: (1) heparin should be administered according to body weight; (2) following trauma, operation or acute vascular accidents, natural anticoagulants may potentiate the effect of heparin; (3) protamine sulfate should always be on hand and its injection repeated every four hours until hemorrhage stops; (4) hemorrhage continuing in spite of administration of protamine is a rare self-perpetuating mechanism uninfluenced by neutralization of heparin which must be combated by blood transfusions.
SUMMARY
An emulsion of heparin in gelatin, given with a daily control of capillary coagulation times, is a simple efficient anticoagulant therapy. The great variability of response to heparin makes set schedules of dosage impossible. The therapeutic dose should always be double the prophylactic dose; in the case of an acute thromboembolic episode, the administration of heparin should be maintained for two weeks.
The determination of heparin tolerance gix es a good insight into the state of the clotting mechanism; it can be done in vivo or in vitro.
